High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors
Open Access
- 1 July 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (2), 153-160
- https://doi.org/10.1038/sj.bmt.1702475
Abstract
Forty-two patients (29 newly diagnosed) with high grade gliomas (n = 37), medulloblastoma (n = 2) or non-biopsied tumors (n = 3) with supratentorial (n = 24), brain stem (n = 11), posterior fossa (n = 5) or spinal (n = 2) location were eligible for this study with adequate organ function and no bone marrow tumor infiltration. Median patient age was 12.2 years (range, 0.7–46.8). A total of 600 mg/m2 BCNU, 900 mg/m2 thiotepa and 1500 or 750 mg/m2 etoposide (VP-16) was administered followed by autologous bone marrow reinfusion (ABMR). Twenty-one newly diagnosed patients received local irradiation (RT) post ABMR. Nine early deaths were observed (21%), as well as one secondary graft failure. Half of the patients aged 18 years or older experienced toxic deaths, whereas only 15% of patients younger than 18 years experienced toxic death (P = 0.05). Of 25 evaluable newly diagnosed patients, 20% achieved complete remission (CR) and 4% partial remission (PR), while 28% remained in continuing complete remission (CCR) and 44% remained with stable disease prior to RT. Of eight evaluable patients with recurrent disease, one achieved CR and two PR, while one remained in CCR and four with stable disease for 1 to 110.2 months. Overall survival was 36%, 24% and 17% at 1, 2 and 3 years following ABMR, with three newly diagnosed patients and one patient treated for recurrent disease being alive, without disease progression 64.4, 67.0, 86.3 and 110.2 months after ABMR, respectively. The combination of high-dose BCNU/ thiotepa/VP-16 has substantial toxicity but definite activity for high risk CNS tumors. Similar protocols with lower toxicity merit further evaluation in both newly diagnosed and recurrent CNS tumors. Bone Marrow Transplantation (2000) 26, 153–160.Keywords
This publication has 22 references indexed in Scilit:
- Surveillance Scanning of Children with MedulloblastomaNew England Journal of Medicine, 1994
- Do anticancer agents reach the tumor target in the human brain?Cancer Chemotherapy and Pharmacology, 1992
- Association between Neuroepithelial Tumor and Multiple Intestinal Polyposis (Turcot's Syndrome): Report of a Case and Critical Analysis of the LiteratureNeurosurgery, 1991
- High-dose multi-agent chemotherapy followed by bone marrow ‘rescue’ for malignant astrocytomas of childhood and adolescenceJournal of Neuro-Oncology, 1990
- The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trialJournal of Neuro-Oncology, 1989
- Cystic pilocytic astrocytomas of the cerebral hemispheresJournal of Neurosurgery, 1985
- High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiformeJournal of Neurosurgery, 1981
- A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored SamplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Contributions to the Theory of Rank Order Statistics-the Two-Sample CaseThe Annals of Mathematical Statistics, 1956